TAYLOR WATSON: Open Payments
NPI 1902531577 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 69 payments from 14 companies in 2025. Trend: 2023 $900 · 2024 $1,064 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $255 |
| Vanda Pharmaceuticals Inc. | 8 | $253 |
| Otsuka America Pharmaceutical, Inc. | 12 | $212 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $164 |
| Janssen Pharmaceuticals, Inc | 4 | $90 |
| Indivior Inc. | 4 | $83 |
| Braeburn Inc. | 4 | $67 |
| Almatica Pharma LLC | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Noven Therapeutics, LLC | 3 | $44 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, INVEGA SUSTENNA, SUBLOCADE, ABILIFY MAINTENA, BRIXADI.
Industry payments across OH — which companies pay providers there.
